Department of Investigational Cancer Therapeutics (A Phase 1 Program), Division of Cancer Medicine, The University of MD Anderson Cancer Center, Houston, TX 77030, USA
Dr. Vivek Subbiah
Department of Investigational Cancer Therapeutics (A Phase 1 Program), Division of Cancer Medicine, The University of MD Anderson Cancer Center, Houston, TX 77030, USA